T37.2 Poisoning by, adverse effect of and underdosing of antimalarials and drugs acting on other blood protozoa

Name of the Condition

• Poisoning by, adverse effect of and underdosing of antimalarials and drugs acting on other blood protozoa

Summary

This condition encompasses poisoning, adverse effects, or underdosing related to antimalarial and other blood protozoa-targeting medications. It includes unintended toxic reactions, harmful side effects, or insufficient dosing of these agents, which may affect treatment efficacy or patient safety.

Causes

Poisoning or adverse effects can result from accidental or intentional overdose, incorrect administration, drug interactions, or allergic reactions to antimalarial or blood protozoa drugs. Underdosing may occur due to subtherapeutic dosing, patient non-adherence, or formulation errors.

Risk Factors

• Concurrent use of multiple medications increasing interaction risk.
• Pre-existing renal or hepatic impairment affecting drug metabolism.
• History of allergic reactions to similar drug classes.
• Lack of proper medication monitoring or dosage adjustments.

Symptoms

• Nausea, vomiting, or gastrointestinal distress.
• Dizziness, confusion, or central nervous system effects.
• Skin rashes, itching, or hypersensitivity reactions.
• Signs of underdosing, such as unresolved infection or treatment failure.

Diagnosis

Clinical evaluation focuses on medication history, symptom onset, and lab tests (e.g., drug levels, renal/hepatic function). Imaging or other studies may be used to assess organ involvement or infection progression.

Treatment Options

Management depends on the severity and type of exposure. For poisoning, decontamination, supportive care, and specific antidotes (if available) may be used. Adverse effects often require discontinuation or dose adjustment of the offending drug. Underdosing may necessitate re-evaluation of dosing regimens or adherence strategies.

Prognosis and Follow-Up

Prognosis varies based on the drug, dose, and patient factors. Mild cases may resolve with discontinuation, while severe poisoning can lead to organ damage. Follow-up includes monitoring for delayed effects, adherence support, and repeat testing if needed.

Complications

• Organ toxicity (e.g., hepatic, renal, or hematologic).
• Severe allergic reactions (e.g., anaphylaxis).
• Treatment failure due to underdosing.
• Long-term sequelae from toxic exposure.

Lifestyle & Prevention

• Use medications as prescribed and avoid self-adjusting doses.
• Inform healthcare providers of all medications to prevent interactions.
• Store drugs safely to avoid accidental ingestion.
• Follow travel or endemic area guidelines for antimalarial prophylaxis.

When to Seek Professional Help

Seek immediate care for suspected overdose, severe allergic reactions, or worsening symptoms (e.g., confusion, organ dysfunction). Contact a provider for unresolved infections or concerns about dosing.

Tips for Medical Coders

Document the specific antimalarial or blood protozoa drug involved, the nature of the event (poisoning, adverse effect, or underdosing), and any contributing factors (e.g., overdose, interaction). Ensure clinical correlation with medication history and symptom presentation.